Executive Chair
Current
Sep 2024 - Present
AeroLeads people directory · profile
Peter Smith Email & Phone Number
CEO start up
at
Race Oncology
1 work email found
@alchemia.com.au
LinkedIn matched
✓ Verified May 2026
4 data sources
Profile completeness 100%
Who is Peter Smith? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Peter Smith is listed as CEO start up at Race Oncology, based in Melbourne, Victoria, Australia. AeroLeads shows a work email signal at alchemia.com.au and a matched LinkedIn profile for Peter Smith.
Peter Smith previously worked as Executive Chair at Race Oncology and Executive Director at Race Oncology. Peter Smith holds Ph.D., Biochemistry from University Of Cambridge.
Company email context
Email format at Race Oncology
This section adds company-level context without repeating Peter Smith's masked contact details.
{first_initial}{last}@alchemia.com.au
86% confidence
AeroLeads found 1 current-domain work email signal for Peter Smith. Compare company email patterns before reaching out.
Profile bio
About Peter Smith
An experienced biotechnology executive with a deep understanding of science, finance and strategy.
Listed skills include Biotechnology, Oncology, Biopharmaceuticals, Pharmaceutical Industry, and 42 others.
Current workplace
Peter Smith's current company
Company context helps verify the profile and gives searchers a useful next step.
14 roles
Peter Smith work experience
A career timeline built from the work history available for this profile.
Executive Director
Sep 2023 - Sep 2024
Non Executive Director
Race Oncology (ASX: RAC) is an ASX-listed clinical stage, global biotechnology company with a dedicated mission to be at the heart of cancer care.Race’s lead asset, bisantrene, is a small molecule anthracene chemotherapeutic. Bisantrene has a unique and rich clinical history with demonstrated therapeutic benefits in both adult and paediatric patients, a.
Jul 2023 - Aug 2023
Non Executive Director
CurrentMycRx has had an active Myc drug discovery program for >4 years. It has built a solid body of holistic data demonstrating that its small molecules directly engage Myc, leading to on-target downstream anti-cancer effects and resulting in the degradation of Myc protein. The Company is now focused on the transition of its promising exemplar chemistry into.
Feb 2018 - Present
Founder And Ceo
Current
Amala Therapeutics
Amala Therapeutics is a biotech start-up focused on preserving muscle in diseased states.
Aug 2015 - Present
Non Executive Director
Hula Therapeutics Inc. is focused on delivering better therapies for children and young adults with cancer. It is a collaboration between Children's Hospital of Philadelphia (CHOP) and Myrio Therapeutics, using CHOP's disease expertise and target identification with Myrio's novel antibody platform. Two programs should enter the clinic in 2024, the first.
Jan 2022 - Mar 2024
Chief Executive Officer
Cancer will have no place to hide...Myrio Therapeutics ("Myrio", formerly Affinity Bioscience) is revolutionizing the field of immuno-oncology by enabling antibody-based therapies to attack targets that are inside cells. Proteins inside cells are routinely broken down into peptides which are displayed on the cell surface by Major Histocompatibility Complex.
Nov 2016 - Oct 2023
Owner
Psmith Consulting
Feb 2013 - Oct 2016
Ceo
Avipep Pty Ltd
Nov 2014 - May 2015
Ceo
Alchemia Limited
Mar 2006 - Jan 2013
Ceo
Amrad Corporation (Renamed Zenyth, Acquired By Csl)
Sep 2003 - Jul 2005
Founder And Cfo
Jan 1997 - Sep 2002
Pharmaceuticals Analyst
Big Cap European pharma analyst. Also involved in brokerships/IPOs of several biotechnology companies.
Sep 1993 - Dec 1996
Pharmaceutical Analyst
May 1988 - Jun 1993
2 education records
Peter Smith education
Ph.D., Biochemistry
University Of Cambridge
B.A., Natural Sciences
University Of Cambridge
FAQ
Frequently asked questions about Peter Smith
Quick answers generated from the profile data available on this page.
What company does Peter Smith work for?
Peter Smith works for Race Oncology.
What is Peter Smith's role at Race Oncology?
Peter Smith is listed as CEO start up at Race Oncology.
What is Peter Smith's email address?
AeroLeads has found 1 work email signal at @alchemia.com.au for Peter Smith at Race Oncology.
Where is Peter Smith based?
Peter Smith is based in Melbourne, Victoria, Australia while working with Race Oncology.
What companies has Peter Smith worked for?
Peter Smith has worked for Race Oncology, Mycrx, Amala Therapeutics, Hula Therapeutics, and Myrio Tx.
How can I contact Peter Smith?
You can use AeroLeads to view verified contact signals for Peter Smith at Race Oncology, including work email, phone, and LinkedIn data when available.
What schools did Peter Smith attend?
Peter Smith holds Ph.D., Biochemistry from University Of Cambridge.
What skills is Peter Smith known for?
Peter Smith is listed with skills including Biotechnology, Oncology, Biopharmaceuticals, Pharmaceutical Industry, Lifesciences, Commercialization, Immunology, and Clinical Trials.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial